GLP-1s Combined With Healthy Habits May Improve Heart Health in Diabetes

A recent study in The Lancet Diabetes & Endocrinology found that people with type 2 diabetes who used GLP-1 receptor agonists (GLP-1 RAs) and followed healthy lifestyle habits had a lower risk of major adverse cardiovascular events (MACE) than those who did not. Researchers analyzed lifestyle habits, GLP-1 RA use, and cardiovascular outcomes in more than 98,000 adults with type 2 diabetes and no prior cardiovascular disease.

Background and scope
– Type 2 diabetes affects an estimated 40.1 million people in the United States (about 12% of the population), and prevalence is projected to rise substantially by 2030.
– GLP-1 RAs (for example, medicines in the class such as Ozempic, Wegovy, and Mounjaro) help manage diabetes by increasing insulin secretion, reducing liver glucose output, slowing gastric emptying, curbing appetite, promoting weight loss, and lowering blood sugar.

Key findings
– Use of a GLP-1 RA combined with adherence to multiple healthy lifestyle habits was associated with the greatest reduction in cardiovascular risk.
– Individuals who used a GLP-1 RA and followed six to eight healthy habits had a 43% lower risk of MACE than people who did not use a GLP-1 RA and followed three or fewer habits.
– People adhering to all eight healthy habits had a 60% reduced MACE risk compared with those adhering to one or fewer habits.
– Overall, GLP-1 RA use alone was associated with a 16% lower MACE risk versus nonuse.

Lifestyle habits and clinical perspective
– The study emphasized that lifestyle interventions remain central to diabetes management and can amplify the cardiovascular benefits of modern pharmacotherapy. Examples of heart-healthy habits cited include a healthy diet, regular physical activity, sufficient quality sleep, stress management, avoiding tobacco and excessive alcohol, and maintaining social connections.
– Clinicians not involved in the study noted it is unsurprising that combining medication and healthy lifestyle changes yields additive benefits for cardiovascular risk reduction.

Limitations
– The analysis was observational, so residual confounding (for example, by socioeconomic factors) cannot be fully excluded despite adjustment.
– The study population was predominately white male veterans, which may limit generalizability, though the findings were reported as consistent across racial, ethnic, and sex subgroups.

Implications
– From a public health perspective, the authors argue that population-level investments and policies promoting healthy diets, physical activity, sleep, stress management, and social connection remain essential, even as novel therapies expand.
– For individuals with diabetes, combining effective medications like GLP-1 RAs with sustained healthy lifestyle habits may offer the largest cardiovascular benefit.

A recent study in The Lancet Diabetes & Endocrinology found that people with type 2 diabetes who used GLP-1 receptor agonists (GLP-1 RAs) and followed healthy lifestyle habits had a lower risk of major adverse cardiovascular events (MACE) than those who did not. The researchers analyzed data from more than 98,000 adults with type 2 diabetes and no prior cardiovascular disease.

Background and context
Type 2 diabetes is widespread in the United States, overlapping with the obesity epidemic. The CDC estimates about 40.1 million people in the U.S. have diabetes (diagnosed or undiagnosed), roughly 12% of the population. Research has projected a 54% increase in prevalence by 2030, to about 54.9 million people.

Study design and findings
The study assessed GLP-1 RA use, adherence to multiple healthy lifestyle habits, and cardiovascular outcomes. While the paper considered eight healthy habits, the central findings were:

– Individuals who used a GLP-1 RA and adhered to six to eight healthy habits had a 43% lower risk of MACE than those who did not use a GLP-1 RA and followed three or fewer habits.
– People who adhered to all eight healthy habits had a 60% reduced risk of MACE compared with those adhering to one or fewer habits.
– Independent of lifestyle, GLP-1 RA use was associated with a 16% lower risk of MACE compared with nonuse.

MACE typically refers to major cardiovascular outcomes such as heart attack, stroke, and cardiovascular death. The results indicate that GLP-1 RAs and healthy lifestyle behaviors each contribute to cardiovascular risk reduction and that their benefits are additive.

Expert perspectives
Frank Hu, MD, professor and chair of the Department of Nutrition at the Harvard T.H. Chan School of Public Health and the study’s corresponding author, said the findings underscore that lifestyle habits remain central to diabetes management and cardiovascular risk reduction, even alongside effective pharmacotherapy.

Cheng-Han Chen, MD, an interventional cardiologist not involved in the study, noted that GLP-1 RAs are known to benefit cardiovascular health and that combining these drugs with heart-healthy diet, regular physical activity, adequate sleep, and other healthy behaviors would be expected to have additive effects.

Mechanism of GLP-1 RAs
GLP-1 receptor agonists, such as semaglutide and tirzepatide-class medications, mimic the natural incretin hormone GLP-1. They enhance insulin secretion, reduce hepatic glucose production, slow gastric emptying, curb appetite, promote weight loss, and lower blood glucose — mechanisms that help manage type 2 diabetes and reduce cardiometabolic risk.

Public health implications
From a population perspective, the authors emphasize continued investment in policies and programs that promote healthy diet, physical activity, sleep, stress management, and social connection. Scalable lifestyle interventions remain essential to lower the overall burden of cardiovascular disease, even as novel therapies expand.

Limitations
The authors acknowledge limitations: the study was observational, so residual confounding by socioeconomic and other factors is possible despite statistical adjustments. The study population was predominantly white male veterans, which may limit generalizability, although findings were reported to be consistent across racial and ethnic groups and between sexes.

Practical recommendations
Clinicians and patients should view GLP-1 RAs as one component of comprehensive diabetes care. Maintaining healthy habits — including a heart-healthy diet, regular physical activity, avoiding tobacco and excessive alcohol, managing stress, fostering social connections, and getting quality sleep — remains important for long-term diabetes control and cardiovascular risk reduction.